- Adherence, antiemetics, cancer, chemotherapy-induced nausea and vomiting (CINV), guidelines. (emjreviews.com)
- Patients indicate that among the most feared side effects of cancer are chemotherapy-induced nausea and vomiting (CINV), with up to 80% of patients affected if appropriate prophylaxis is not administered. (emjreviews.com)
- CINV affects patient quality of life, may interfere with chemotherapy compliance which can possibly influence cancer survival outcomes, and results in greater healthcare resource utilisation. (emjreviews.com)
- Next Frontier Pharmaceuticals is also pursuing a 505(b)(2) approval pathway with the FDA for several Investigational New Drugs (INDs) for indications including opioid withdrawal, pain, migraines, and nausea and vomiting associated with chemotherapy. (minstercommunitypost.com)
- Today, with the signing of the merger agreement with Next Frontier Pharmaceuticals, we will have the foundational drug development and formulation team and manufacturing assets to become such a leader. (minstercommunitypost.com)
- Advances in nanotechnology resulted in the development of targeted and multifunctional nanoscale drug constructs. (preprints.org)
- A 505(b)(2) New Drug Application (NDA) for HTX-019 for the prevention of postoperative nausea and vomiting (PONV) in adults was submitted to the U.S. Food and Drug Administration (FDA) in November 2021 . (herontx.com)
- Upon the closing of the transaction, the combined company intends to become a leading drug developer and manufacturer of pharmaceutical cannabinoids and psychedelics with a growing portfolio of drug products and intellectual property. (jupiterwellness.com)
- Postoperative nausea and vomiting (PONV) represents a significant market opportunity in the acute care setting that leverages our existing sales organization. (herontx.com)
- Zuplenz® is marketed in the US for the prevention of chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV) and has a target market of $4.6bn by 2018. (traderpower.com)
- RBT will provide manufacturing, distribution, sales and marketing expertise and KER will contribute sales and marketing expertise, technical support and research and development to the partnership. (traderpower.com)
- With its industry-leading cannabinoid platform, innovative products, and pipeline, we strongly believe that Next Frontier Pharmaceuticals positions us well for long-term stockholder value creation," said Brian John, Chief Executive Officer of Jupiter Wellness. (jupiterwellness.com)
- With our FDA approved SYNDROS® drug, we intend to expand our platform of drug products to create novel therapies for pain, inflammation, and insomnia, among other ailments. (jupiterwellness.com)
- RiceBran Technologies (NASDAQ: RIBT and RIBTW) (the "Company" or "RBT"), a global leader in the production and marketing of value added products derived from rice bran, today announced that the Company has entered into a 10 year Exclusive Supply and Cooperation Agreement covering the North American equine market with Kentucky Equine Research ("KER"), an international equine nutrition, research, and consultation company serving horse owners and the feed industry. (traderpower.com)
- RiceBran Technologies is a human food ingredient and animal nutrition company focused on the procurement, bio-refining and marketing of numerous products derived from rice bran. (traderpower.com)
- OXFORDSHIRE, United Kingdom, Dec. 30, 2015 - Midatech Pharma ("Midatech" or the "Company" or the "Group") (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical company focused on developing and commercialising products in oncology and other therapeutic areas, today announces the successful completion of its previously announced acquisition of Zuplenz® (ondansetron), a marketed oncology product from Galena Biopharma, Inc. (NASDAQ:GALE). (traderpower.com)
- Our target markets are human food ingredients and animal nutrition manufacturers and retailers, as well as natural food, functional food and nutritional supplement manufacturers and retailers, both domestically and internationally. (traderpower.com)
- It is a pleasure and an honor to have the opportunity to cooperate with Joe and KER to increase market penetration for both of our companies as we work to bring new, high value equine feeds and supplements to the North American equine market. (traderpower.com)
- Today, with the signing of the merger agreement with Next Frontier Pharmaceuticals, we will have the foundational drug development and formulation team and manufacturing assets to become such a leader. (jupiterwellness.com)